Apimeds Pharmaceuticals US (APUS) Free Cash Flow (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) reported Free Cash Flow of -$3.8 million for Q4 2025, down 3754.43% on a YoY basis from $105067.8 in Q4 2024, and down 119.57% quarter-over-quarter from -$1.7 million in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Free Cash Flow (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US has reported Free Cash Flow for 2 years, with the latest figure at -$3.8 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow fell 3754.43% year-over-year to -$3.8 million; the trailing twelve-month figure through Dec 2025 stood at -$9.0 million (down 1122.83% YoY), and the FY2025 full-year result was -$9.0 million, down 1124.65% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$3.8 million, down from -$1.7 million in the prior quarter.
- The five-year high for Free Cash Flow was -$20313.0 in Q1 2025, with the low at -$3.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Apimeds Pharmaceuticals US | 13.93 Mn | 10.29 Mn | - | -3.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.84 Mn |
| Dec 31, 2025 | -3.84 Mn |
| Sep 30, 2025 | -1.75 Mn |
| Sep 30, 2025 | -1.75 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | -20,313.00 |
| Mar 31, 2025 | -20,313.00 |
| Dec 31, 2024 | -99,616.00 |
| Dec 31, 2024 | -99,616.00 |
| Sep 30, 2024 | -186,755.00 |
| Sep 30, 2024 | -186,755.00 |
| Jun 30, 2024 | -184,055.00 |
| Jun 30, 2024 | -184,055.00 |
| Mar 31, 2024 | -263,100.00 |
| Mar 31, 2024 | -263,100.00 |